Response Genetics Inc (NASDAQ:RGDX)
| 1.42 Data as of May 24 |  0.00 / 0.00%Today’s Change | 0.70 Today|||52-Week Range 2.05 | +2.16% Year-to-Date |
Latest RGDX News | Press Releases
No recent news for Response Genetics Inc.
Today’s Trading
| Previous close | 1.42 |
| Today’s open | 1.43 |
| Day’s range | 1.40 - 1.43 |
| Volume | 18,821 |
| Average volume (3 months) | 30,041 |
| Market cap | $46.6M |
| Dividend yield | -- |
Data as of 4:00pm ET, 05/24/2013
Growth & Valuation
| Earnings growth (last year) | +3.33% |
| Earnings growth (this year) | +51.72% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -17.25% |
| P/E ratio | NM |
| Price/Sales | 1.98 |
| Price/Book | -- |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| BGMDBG Medicine Inc | -0.07 | -3.91% |
| DMPIDelMar Pharmaceutica... | +0.15 | +7.50% |
| NBYNovaBay Pharmaceutic... | -0.03 | -2.56% |
| HSKAHeska Corp | -0.11 | -1.40% |
Data as of 4:00pm ET, 05/24/2013
Financials
| Next reporting date | August 13, 2013 |
| EPS forecast (this quarter) | -$0.04 |
| Annual revenue (last year) | $18.7M |
| Annual profit (last year) | -$7.8M |
| Net profit margin | -41.40% |
Profile
Sector Health Technology |
Industry Biotechnology |
Chairman & Chief Executive Officer Thomas A. Bologna, MBA |
Chief Financial Officer Kevin Roy Harris, CPA |
Corporate headquarters Los Angeles, California |
Forecasts
